Standard biotools stock news
Webb12 apr. 2024 · Indee Labs to complete the development and launch of Hydropore RUO and Cell Therapy along with a direct DNA knock-in kit, enabled by BroadOak's strategic investment and domain expertise. BERKELEY ... Webb4 apr. 2024 · Fluidigm has been renamed Standard BioTools Inc. (“Standard BioTools”) and its common stock is expected to begin trading on Nasdaq under the symbol “LAB” as of …
Standard biotools stock news
Did you know?
Webb27 mars 2024 · Standard Biotools stock last closed at $2.03, down 1.93% from the previous day, and has decreased 43.3% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.3 percentage points. Standard Biotools stock is currently +120.65% from its 52-week low of $0.92, and -52.01% from its 52-week high of … Webb免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。
WebbStandard BioTools - Funding, Financials, Valuation & Investors Oops! There was a problem! There was an unexpected issue while trying to process your request. Please refresh the page and try again. If the problem persists, please contact support. Refresh Webb6 mars 2024 · Nasdaq Standard BioTools Inc. News All News LAB US34385P1084 STANDARD BIOTOOLS INC. (LAB) Add to my list Report Summary Quotes Charts News …
Webb13 apr. 2024 · LAB Stock Overview Standard BioTools Inc., together with its subsidiaries, creates, manufactures, and markets instruments, consumables, reagents, and software … WebbStandard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents.
Webb12 maj 2024 · Standard BioTools Stock (NASDAQ: LAB) stock price, news, charts, stock research, profile. News Press Releases Partners Insiders Buy More Than $3M Of 3 Penny Stocks Lisa Levin - Jun...
WebbStandard BioTools Inc. Stock Prediction 2025. The Standard BioTools Inc. stock prediction for 2025 is currently $ 1.411348, assuming that Standard BioTools Inc. shares will continue growing at the average yearly rate as they did in the last 10 years.This would represent a -18.42% increase in the LAB stock price.. Standard BioTools Inc. Stock Prediction 2030 tree surgeon heathfield east sussexWebbStandard BioTools Inc. $ 2.17 $ 0.11 (5.10%) Trade Now Your capital is at risk. Other fees may apply. Overview Brokers News Prediction Standard BioTools Inc. News Currently, there are no news for Standard BioTools Inc. stock. We will do our best to add new news sources to include LAB news. tree surgeon employment outlookWebb12 apr. 2024 · Standard BioTools (NASDAQ:LAB) has a market capitalization of $141.52 million and generates $97.95 million in revenue each year. The company earns $ … tree surgeon emsworthWebbför 2 dagar sedan · 4/12/2024 8:03:23 AM. ( MENAFN - PR Newswire) Indee Labs to complete the development and launch of Hydropore RUO and Cell Therapy. along with a direct DNA knock-in kit, enabled by BroadOak's ... temok rails hostingWebbStock Symbol LAB Investments 3 Share Price $1.79 (As of Thursday Closing) General Information Description Standard BioTools Inc manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. The company's segments include Proteomics and Genomics. tree surgeon huntingdonshireWebb21 mars 2024 · Standard BioTools News All News TipRanks News Press Releases Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635 (c) (4) SOUTH SAN FRANCISCO, Calif., March 22, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB) today announced... 16h ago LAB Standard BioTools … tree surgeon fordingbridgeWebb13 apr. 2024 · Standard BioTools - LAB Competitors $2.10 -0.07 (-3.23%) (As of 03/17/2024 12:00 AM ET) Compare Today's Range $2.03 $2.15 50-Day Range $1.65 $2.24 52-Week Range $0.92 $4.23 Volume 271,832 shs Average Volume 245,246 shs Market Capitalization $166.53 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile Chart … temoin serment